Chrysostomi Gialeli
Lund, M 22100, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Elevated Asporin expression in human atherosclerotic plaques promotes their stability and reduces the risk for cardiovascular events.
Journal: Cardiovascular research
Published: April 28, 2025
TWIST1 drives endothelial-to-mesenchymal-transition to stabilize atherosclerotic plaques.
Journal: Nature communications
Published: April 18, 2025
LIGHT/TNFSF14 Levels in Carotid Plaques Are Associated With Symptomatic Cerebrovascular Disease.
Journal: Journal of stroke
Published: February 11, 2025
Alternative Complement Pathway in Carotid Atherosclerosis: Low Plasma Properdin Levels Associate With Long-Term Cardiovascular Mortality.
Journal: Journal of the American Heart Association
Published: January 27, 2025
Spatial transcriptomics reveals a key role of fibroblast-like vascular smooth muscle cells in human atherosclerotic cell crosstalk and stability.
Journal: European heart journal
Published: January 18, 2025
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma.
Journal: Cancer immunology, immunotherapy : CII
Published: January 22, 2024
Identification of an osteopontin-derived peptide that binds neuropilin-1 and activates vascular repair responses and angiogenesis.
Journal: Pharmacological research
Published: December 28, 2023
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 21, 2023
CSMD1 regulates brain complement activity and circuit development.
Journal: Brain, behavior, and immunity
Published: November 20, 2023
Atherosclerotic plaque features relevant to rupture-risk detected by clinical photon-counting CT ex vivo: a proof-of-concept study.
Journal: European radiology experimental
Published: September 15, 2023
Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 29, 2023
Last Updated: 09/26/2026